Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Mark Fussa"'
Autor:
Anthony Fryckberg, Nikunj Vyas, Kathryn H Kerr, Gauri Chauhan, Cindy Hou, Joseph DeRose, Mark Condoluci, Zeina Ghayad, Mark Fussa, Shereef Ali, James Williams, Todd P Levin, Michael Barnish, Scott W Scheiblein
Publikováno v:
Open Forum Infectious Diseases
Background Tocilizumab (TCZ) is a monoclonal antibody against the interleuikin-6 receptor which is potentially beneficial in COVID-19 induced cytokine release syndrome (CRS). However, there are limited studies showing anti-inflammatory effect and cli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::80d10496ae3d0f3fcf28a2b37a473331
http://europepmc.org/articles/PMC7777636
http://europepmc.org/articles/PMC7777636
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America. 55(2)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::caf80a480e048ba35cdc0c42c01a7c4b
https://pubmed.ncbi.nlm.nih.gov/22730353
https://pubmed.ncbi.nlm.nih.gov/22730353
Publikováno v:
Clinical Infectious Diseases; Jul2012, Vol. 55 Issue 2, p301-302, 2p
COVID-19 Viral Sepsis: Impact on Disparities, Disability, and Health Outcomes introduces the concepts of viral sepsis, its origins, and its implications. COVID-19 is a leading cause of viral sepsis with considerable impact on morbidity and mortality.
